Zomedica Corp. (ZOM) saw its shares rise on Thursday after announcing the expansion of its distribution partnership with Grovet, granting Grovet exclusive rights to distribute Zomedica’s equine products in 27 European countries. The agreement includes Zomedica’s PulseVet and TRUFORMA platforms, expanding the reach of its equine diagnostics and treatment solutions.